日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Whole-genome sequencing reveals cellular origin of concomitant chronic lymphocytic leukemia and multiple myeloma: a case report

全基因组测序揭示伴随性慢性淋巴细胞白血病和多发性骨髓瘤的细胞起源:病例报告

Zhang, Jianing; Ma, Ji; Li, Ying; Lv, Xiao; Feng, Lili

Angiogenesis of Avascular Necrosis of the Femoral Head: A Classic Treatment Strategy

股骨头缺血性坏死的血管生成:一种经典的治疗策略

Wang, Ping; Shao, Wenkai; Wang, Yuxi; Wang, Bo; Lv, Xiao; Feng, Yong

Research on the application of inertially stabilized platform in the dynamic measurement of cold atomic gravimeter

惯性稳定平台在冷原子重力仪动态测量中的应用研究

Chen, Pei-Jun; Jiang, Min-Rui; Lv, Xiao-Feng; Zhou, Hang; Yang, Di; Zhou, Ying; Jin, Zifan; Peng, Shu-Ping

Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis

度拉糖肽治疗中国2型糖尿病患者的疗效和安全性与基线HbA1c的关系:一项事后分析

Yu, Miao; Yuan, Guo Yue; Zhang, Bin; Wu, Hai Ya; Lv, Xiao Feng

Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma

白细胞介素-9促进弥漫性大B细胞淋巴瘤细胞存活和耐药性

Lv, Xiao; Feng, Lili; Ge, Xueling; Lu, Kang; Wang, Xin

A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol.

一项随机、开放标签、多中心研究,旨在评估接受普罗布考和西洛他唑治疗的 2 型糖尿病和闭塞性动脉硬化患者的血浆动脉粥样硬化生物标志物

Ma Xiao-Wei, Guo Xiao-Hui, Xiao Xin-Hua, Guo Li-Xin, Lv Xiao-Feng, Li Quan-Min, Gao Yan